A Novel Conditional Active Biologic Anti-EpCAM x Anti-CD3 Bispecific Antibody with Synergistic Tumor Selectivity for Cancer Immunotherapy

March 7, 2024

A Novel Dual CAB Nectin-4 x CD3 Bispecific Antibody Targeting Solid Tumors

November 17, 2023

A Novel Conditionally Active Bispecific HER2 X CD-3 T Cell Engager Targeting Solid Tumors

November 13, 2023

A Novel Dual-Cab Nectin-4 X CD3 Bispecific Antibody Targeting Solid Tumors

April 25, 2023

Conditionally Active Biologics Eliminate Senescence Cells in Cancer and Aging

April 18, 2023

Novel Conditionally Active Bispecific HER2 X CD3 T-Cell Engager Targeting Solid Tumors

April 17, 2023

Novel Conditionally Active Bispecific T Cell Engagers Targeting Solid Tumors

February 2, 2023

Novel Conditionally Active Bispecific EpCAM x CD3 T Cell Engagers Targeting Solid Tumors

February 2, 2023

Novel Conditionally Active Bispecific T Cell Engagers Targeting Solid Tumors

February 2, 2023

Novel conditionally active biologic (CAB) antibodies

February 2, 2023